Biotechnology Letters

, Volume 39, Issue 12, pp 1821–1825 | Cite as

Expression and purification of classical swine fever virus E2 protein from Sf9 cells using a modified vector

Original Research Paper



To develop a simple method for efficient expression of classical swine fever virus (CSFV) E2 protein.


The pFastBac HT B vector (pFastHTB-M1) was modified by adding a melittin signal peptide sequence. The E2 gene fragment without the transmembrane region was cloned into pFastHTB-M1. The modified vector has clear advantage over the original one, as evidenced by the purified recombinant E2 protein that was detected significantly by SDS-PAGE.


The modified vector has the potential for large-scale production and easy purification of the CSFV E2 protein or other proteins of interests.


Baculovirus expression system Classical swine fever virus E2 protein Secretory expression 



This work is funded by the National Youth Science Fund of NSFC (National Natural Science Foundation of China) (31101793) and the Ministry of Education (20120101130014).

Supporting information

Supplementary Fig. 1—Schematic map of pFastHTB-M1 vector construction from pFastBacTM HT B (a) and sequencing confirmation (b).

Supplementary Fig. 2—Identification of the recombinant baculovirus genome containing the E2 gene fragment of classical swine fever virus using universal M13 primers and E2-specific primers.

Supplementary material

10529_2017_2426_MOESM1_ESM.docx (3.2 mb)
Supplementary material 1 (DOCX 3254 kb)


  1. Bei R, Schlom J, Kashmiri SVS (1995) Baculovirus expression of a functional single-chain immunoglobulin and its IL-2 fusion protein. J Immunol Method 186:245–255CrossRefGoogle Scholar
  2. Blome S, Meindl-Böhmer A, Loeffen W, Thuer B, Moenning V (2006) Assessment of classical swine fever diagnostics and vaccine performance. OIE Rev Sci Tech 25:1025–1038CrossRefPubMedGoogle Scholar
  3. Clavijo A, Lin M, Riva J, Mallory M, Lin F, Zhou EM (2001) Development of a competitive ELISA using a truncated E2 recombinant protein as antigen for detection of antibodies to classical swine fever virus. Res Vet Sci 70:1–7CrossRefPubMedGoogle Scholar
  4. Drugmand JC, Schneider YJ, Agathos SN (2012) Insect cells as factories for biomanufacturing. Biotechnol Adv 30:1140–1157CrossRefPubMedGoogle Scholar
  5. Felberbaum RS (2015) The baculovirus expression vector system: a commercial manufacturing platform for viral vaccines and gene therapy vectors. Biotechnol J 10:702–714CrossRefPubMedGoogle Scholar
  6. Hsieh P, Robbins PW (1984) Regulation of asparagine-linked oligosaccharide processing. Oligosaccharide processing in Aedes albopictus mosquito cells. J Biol Chem 259:2375–2382PubMedGoogle Scholar
  7. Huang YL, Deng MC, Wang FI, Huang CC, Chang CY (2014) The challenges of classical swine fever control: modified live and E2 subunit vaccines. Virus Res 179:1–11CrossRefPubMedGoogle Scholar
  8. König M, Lengsfeld T, Pauly T, Stark R, Thiel HJ (1995) Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol 69:6479–6486PubMedPubMedCentralGoogle Scholar
  9. Krol E, Pastuch-Gawolek G, Nidzworski D, Rychlowski M, Szeja W, Grynkiewicz G, Szewczyk B (2014) Synthesis and antiviral activity of a novel glycosyl sulfoxide against classical swine fever virus. Bioorg Med Chem 22:2662–2670CrossRefPubMedGoogle Scholar
  10. Kukuruzinska MA, Bergh MLE, Jackson BJ (1987) Protein glycosylation in yeast. Annu Rev Biochem 56:915–944CrossRefPubMedGoogle Scholar
  11. Leifer I, Ruggli N, Blome S (2013) Approaches to define the viral genetic basis of classical swine fever virus virulence. Virology 438:51–55CrossRefPubMedGoogle Scholar
  12. Lin GJ, Deng MC, Chen ZW, Liu TY, Wu CW, Cheng CY, Chien MS, Huang C (2012) Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission. Vaccine 30:2336–2341CrossRefPubMedGoogle Scholar
  13. Pijlman GP, de Vrij J, van den End FJ, Vlak JM, Martens DE (2004) Evaluation of baculovirus expression vectors with enhanced stability in continuous cascaded insect-cell bioreactors. Biotechnol Bioeng 87:743–753CrossRefPubMedGoogle Scholar
  14. Schroeder S, von Rosen T, Blome S, Loeffen W, Haegeman A, Koenen F, Uttenthal A (2012) Evaluation of classical swine fever virus antibody detection assays with an emphasis on the differentiation of infected from vaccinated animals. Rev Sci Tech Int Off Epizoot 31:997–1010CrossRefGoogle Scholar
  15. van Rijn PA, Bossers A, Wensvoort G, Moormann RJ (1996) Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J Gen Virol 77:2737–2745CrossRefPubMedGoogle Scholar
  16. Verma R, Boleti E, George AJT (1998) Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. J Immunol Methods 216:165–181CrossRefPubMedGoogle Scholar
  17. Xia H, Harimoorthy R, Vijayaraghavan B, Blome S, Widén F, Beer M, Belák S, Liu L (2014) Differentiation of classical swine fever virus infection from CP7_E2alf marker vaccination by a multiplex microsphere immunoassay. Clin Vaccine Immunol 22:65–71CrossRefPubMedPubMedCentralGoogle Scholar
  18. Zhou B, Liu K, Jiang Y, Wei JC, Chen PY (2011) Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response. Virol J 8:378CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  1. 1.Institute of Preventive Veterinary Medicine and Zhejiang Provincial Key Laboratory of Preventive Veterinary MedicineZhejiang UniversityHangzhouChina

Personalised recommendations